Biostar Stock Soars (BSPM)

NEW YORK ( TheStreet) -- Shares of Biostar Pharmaceuticals (Nasdaq: BSPM) have taken a tremendous swing upward. The stock is trading at $1.78 as of 10:33 a.m. ET, 21.1% above Wednesday's closing price of $1.47. Volume is at 669,682, 11.7 times the daily average of 57,200.

Biostar has a market cap of $10.1 million and is part of the health care sector and drugs industry. Shares are up 75.8% year to date as of the close of trading on Wednesday.

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products, and health supplement products for various diseases and conditions in the People's Republic of China. The company has a P/E ratio of 0.9, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Biostar as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. You can view the full Biostar Ratings Report.

See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center.